drugset / Trial / NCT04101708
A Comparison of High-dose Dual Therapy and Half-dose Clarithromycin-containing Bismuth Quadruple Therapy for H.P Eradication in Elderly Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess and compare the effectiveness and safety of high-dose dual therapy and half-dose clarithromycin-containing bismuth quadruple therapy in elderly patients for eradicating H.pylori.
Timeline
- Start
- 2019-09-20
- Primary completion
- 2021-09-20
- Completion
- 2022-09-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amoxicillin | Other / unclassified | 750 mg | Oral |
| Comparator | Amoxicillin | Other / unclassified | 1000 mg | Oral |
| Comparator | Clarithromycin | Small molecule | 250 mg | Oral |
| Comparator | Lansoprazole | Other / unclassified | 30 mg | Oral |
| Comparator | bismuth subcitrate | Unknown | 200 mg | Oral |